Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial

Background Gynecologic laparotomy surgery often leads to moderate to severe pain. Effective analgesia is essential for patient postoperative recovery. We aimed to evaluate the effect of low-dose esketamine on quality of recovery when used as part of multimodal analgesia in patients undergoing open g...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi-Yu Geng, Yan Zhang, Xin Yan, Jun Hu, Ran Cui, Lin-Lin Song, Hui-Cheng Song
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2546675
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765146631602176
author Zhi-Yu Geng
Yan Zhang
Xin Yan
Jun Hu
Ran Cui
Lin-Lin Song
Hui-Cheng Song
author_facet Zhi-Yu Geng
Yan Zhang
Xin Yan
Jun Hu
Ran Cui
Lin-Lin Song
Hui-Cheng Song
author_sort Zhi-Yu Geng
collection DOAJ
description Background Gynecologic laparotomy surgery often leads to moderate to severe pain. Effective analgesia is essential for patient postoperative recovery. We aimed to evaluate the effect of low-dose esketamine on quality of recovery when used as part of multimodal analgesia in patients undergoing open gynecologic surgery.Methods 140 female patients undergoing gynecologic laparotomy under general anesthesia were randomly assigned to receive intraoperative infusion of either 0.25 mg/kg/h esketamine (study group) or an equivalent volume of normal saline (control group). The primary outcome was quality of recovery at 24 h postoperatively, assessed using the 40-item quality of recovery questionnaire (QoR-40). Secondary outcomes included morphine consumption, pain scores, functional outcomes, adverse events, postoperative depressive symptom, chronic pain, and health-related quality of life.Results The global QoR-40 score at 24 h was not significantly different between the two groups [study group, 178 (165–186); control group, 175 (164–186); median difference, 2; 95% CI, −3 to 7; p = 0.467). Secondary outcomes were comparable between the two groups. More patients in the study group had extubation time ≥ 10min (15.7% vs. 2.9%; p= 0.009) and were over sedated (25.7 vs. 4.3%, p < 0.001) during post-anesthesia care unit stay.Conclusions Intraoperative infusion of 0.25 mg/kg/h esketamine had no additional benefit on early quality of recovery when used as part of multimodal analgesic regimen in patients undergoing open gynecologic surgery. Future investigations are needed to determine the optimal dosing regimen and identify subgroups of gynecologic patients who would benefit most from esketamine.Trial registration Chinese Clinical Trial Registry; ChiCTR 2200061021.
format Article
id doaj-art-bee4b8d242374a0c841e15cc7d2abe1d
institution DOAJ
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-bee4b8d242374a0c841e15cc7d2abe1d2025-08-20T03:04:57ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2546675Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trialZhi-Yu Geng0Yan Zhang1Xin Yan2Jun Hu3Ran Cui4Lin-Lin Song5Hui-Cheng Song6Department of Anesthesiology, Peking University First Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, ChinaDepartment of Anesthesiology, Peking University First Hospital, Beijing, ChinaSchool of Public Health, Capital Medical University, Beijing, ChinaBackground Gynecologic laparotomy surgery often leads to moderate to severe pain. Effective analgesia is essential for patient postoperative recovery. We aimed to evaluate the effect of low-dose esketamine on quality of recovery when used as part of multimodal analgesia in patients undergoing open gynecologic surgery.Methods 140 female patients undergoing gynecologic laparotomy under general anesthesia were randomly assigned to receive intraoperative infusion of either 0.25 mg/kg/h esketamine (study group) or an equivalent volume of normal saline (control group). The primary outcome was quality of recovery at 24 h postoperatively, assessed using the 40-item quality of recovery questionnaire (QoR-40). Secondary outcomes included morphine consumption, pain scores, functional outcomes, adverse events, postoperative depressive symptom, chronic pain, and health-related quality of life.Results The global QoR-40 score at 24 h was not significantly different between the two groups [study group, 178 (165–186); control group, 175 (164–186); median difference, 2; 95% CI, −3 to 7; p = 0.467). Secondary outcomes were comparable between the two groups. More patients in the study group had extubation time ≥ 10min (15.7% vs. 2.9%; p= 0.009) and were over sedated (25.7 vs. 4.3%, p < 0.001) during post-anesthesia care unit stay.Conclusions Intraoperative infusion of 0.25 mg/kg/h esketamine had no additional benefit on early quality of recovery when used as part of multimodal analgesic regimen in patients undergoing open gynecologic surgery. Future investigations are needed to determine the optimal dosing regimen and identify subgroups of gynecologic patients who would benefit most from esketamine.Trial registration Chinese Clinical Trial Registry; ChiCTR 2200061021.https://www.tandfonline.com/doi/10.1080/07853890.2025.2546675Esketaminegynecologicmultimodal analgesiapostoperativequality of recovery
spellingShingle Zhi-Yu Geng
Yan Zhang
Xin Yan
Jun Hu
Ran Cui
Lin-Lin Song
Hui-Cheng Song
Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
Annals of Medicine
Esketamine
gynecologic
multimodal analgesia
postoperative
quality of recovery
title Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
title_full Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
title_fullStr Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
title_full_unstemmed Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
title_short Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial
title_sort intraoperative low dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery a double blinded parallel group placebo controlled trial
topic Esketamine
gynecologic
multimodal analgesia
postoperative
quality of recovery
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2546675
work_keys_str_mv AT zhiyugeng intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT yanzhang intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT xinyan intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT junhu intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT rancui intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT linlinsong intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial
AT huichengsong intraoperativelowdoseesketamineonpostoperativequalityofrecoveryinpatientsundergoingopengynecologicsurgeryadoubleblindedparallelgroupplacebocontrolledtrial